Telescope Innovations Corp. (CSE:TELI)

Market Cap	34.75M
Revenue (ttm)	4.78M
Net Income (ttm)	-1.56M
Shares Out	80.81M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	83,830
Average Volume	268,566
Open	0.4250
Previous Close	0.4300
Day's Range	0.4100 - 0.4400
52-Week Range	0.2300 - 0.6500
Beta	1.57
RSI	54.02
Earnings Date	Dec 22, 2025

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. It also provides intellectual property and contract research services. It serves pharmaceutical, critical minerals, and chemical industries. Telescope Innovations Corp. has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. ...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Henry Dubina
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TELI

Financial Performance

In 2025, Telescope Innovations's revenue was 4.78 million, an increase of 12.03% compared to the previous year's 4.27 million. Losses were -1.56 million, 18.1% more than in 2024.